Hepatocellular carcinoma: epidemiology and molecular carcinogenesis
about
Lectin of Concanavalin A as an anti-hepatoma therapeutic agentMolecular functions of thyroid hormones and their clinical significance in liver-related diseasesDrug-eluting bead transarterial chemoembolisation for unresectable hepatocellular carcinomaTyrosine kinase inhibitors for unresectable hepatocellular carcinoma in adultsRadiofrequency (thermal) ablation versus no intervention or other interventions for hepatocellular carcinomaDrug-eluting bead transarterial chemoembolisation for unresectable hepatocellular carcinomaTransarterial (chemo)embolisation for unresectable hepatocellular carcinomaCooperative interaction of MUC1 with the HGF/c-Met pathway during hepatocarcinogenesisLate SV40 factor (LSF) enhances angiogenesis by transcriptionally up-regulating matrix metalloproteinase-9 (MMP-9)ARID2: a new tumor suppressor gene in hepatocellular carcinomaInactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinomaAntiproliferative small-molecule inhibitors of transcription factor LSF reveal oncogene addiction to LSF in hepatocellular carcinomaThe transcription factor LSF: a novel oncogene for hepatocellular carcinomaRole of sorafenib in the treatment of advanced hepatocellular carcinoma: An updateTumor-specific expression of microRNA-26a suppresses human hepatocellular carcinoma growth via cyclin-dependent and -independent pathwaysA human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responsesTranscription factor Late SV40 Factor (LSF) functions as an oncogene in hepatocellular carcinomaMultidisciplinary Canadian consensus recommendations for the management and treatment of hepatocellular carcinomaClinical relevance and public health significance of hepatitis B virus genomic variationsActivins and activin antagonists in hepatocellular carcinomaMicroRNA expression, survival, and response to interferon in liver cancerAstrocyte elevated gene-1 regulates hepatocellular carcinoma development and progressionSulfatase 2 up-regulates glypican 3, promotes fibroblast growth factor signaling, and decreases survival in hepatocellular carcinomaMicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to sorafenibIdentification of genes conferring resistance to 5-fluorouracilMethylation mediated silencing of MicroRNA-1 gene and its role in hepatocellular carcinogenesisRole of microRNA-155 at early stages of hepatocarcinogenesis induced by choline-deficient and amino acid-defined diet in C57BL/6 miceTransarterial radioembolization for hepatocellular carcinoma: a reviewRadiotherapy as valid modality for hepatocellular carcinoma with portal vein tumor thrombosisPersonalized Clinical Trials in Hepatocellular Carcinoma Based on Biomarker SelectionMetabolomic analysis of human cirrhosis, hepatocellular carcinoma, non-alcoholic fatty liver disease and non-alcoholic steatohepatitis diseasesCurrent status of laparoscopic liver resection for hepatocellular carcinomaHCV-Induced Oxidative Stress: Battlefield-Winning StrategyEffect of adjuvant interferon therapy on hepatitis B virus-related hepatocellular carcinoma: a systematic reviewHepatocellular Carcinoma: Risk Factors, Diagnosis and TreatmentCirculating tumor DNA in hepatocellular carcinoma: trends and challengesEpidemiology of Hepatocellular Carcinoma in the Asia-Pacific RegionMicroRNAs in the Evaluation and Potential Treatment of Liver DiseasesHepatocellular carcinoma: Review of disease and tumor biomarkersHypoxia-inducible factors as molecular targets for liver diseases
P2860
Q21284430-5EEEB230-F44C-4E6D-919A-904334B3E1A3Q21284820-4CC5478C-E6E9-417F-B703-8DC4E90AC1B9Q24187663-BAE614A7-7155-430C-A8C6-2E3DA91222F7Q24187730-809B7C8C-B430-43A9-B239-272668854DEBQ24201669-A2198476-658C-48B3-9273-36D82A89A5BEQ24202061-03F77FCF-38AD-4A2E-A77B-8D272A7BC57CQ24235977-68605BC6-06AB-4CC8-83AC-5B43DEF3C63EQ24298462-A7C2377F-DF6C-4354-808E-339814AABDB8Q24598701-776FC87F-0C25-4F4C-8747-1CDC200E5BD5Q24607045-BD529914-83F0-4AD7-90D2-CB6A75B55A0CQ24609544-08C2D1D6-A1CA-40F3-82F8-D5D4FE9F1510Q24610751-B6DE0113-D5E7-48BB-84B8-1BB1BAB79FE1Q24613885-34105802-7210-42CB-86FB-933BD463867DQ24619987-71F4B656-5591-4AEA-84D7-1A81A8435F08Q24624119-ED78D9DA-9CFE-4C26-A434-E6BBE2677FBFQ24630221-2F7B4214-DBDD-40EC-811B-0C291218F0DFQ24631107-646AB860-41CB-47DF-AC12-C913FA3B2D1BQ24635267-15196CBF-F5A5-4B9A-93F2-377E99024512Q24644176-A77FE184-52C9-4F26-B318-EFE5AB0E5841Q24646221-A24F1636-C04A-4B1D-ACE8-0DC3D86C40B5Q24647241-39A73317-D26F-4911-AC37-B95B89E0D83DQ24647547-8D7456D0-B2E6-4316-AF00-026EFBCF9857Q24651026-4C3D4C5C-E2EA-4EE5-A681-7288726D67F2Q24655048-B13B4076-337E-4114-98C2-E4B552E5BE29Q24655818-AF78B54A-7356-404D-921F-D541B0000DFFQ24656948-A43F7F94-6F1C-40C9-A807-FD7EC5843136Q24657152-0FF6A591-1EBE-4A33-839E-2B2BB283D09EQ26738273-6CB4090A-0866-4D30-B76A-37230836AD4FQ26738533-28C67082-BC3D-4C7D-9ACA-F3EA1DE8FBF7Q26738860-5F9179B2-905B-42C2-8530-DC35038D304BQ26741550-C0CD4DCF-A8FB-44DE-8628-ADDB1216E203Q26745875-377003D7-381F-40C0-A6CD-43D18B82BD36Q26746946-4EBA5339-17D3-4047-ACE9-8CA41CAB733DQ26747293-62E3DEAD-4DF5-4986-8DCB-7C6372577E72Q26747551-579EC830-B2FD-4ABA-82C8-61147C25B40DQ26749417-CBD32D15-2BF8-4EAB-961B-8E269106B5E9Q26750444-9B66835E-2FC7-45E6-9AC4-EEC4F11BFB4CQ26750448-75ECA6BF-9D97-4AFB-A417-E34DFAA8753AQ26750796-32B6BB0D-5543-4465-B511-0F86E1D58D08Q26752304-2C687B62-96B0-4333-BAC8-BE605A14BE0F
P2860
Hepatocellular carcinoma: epidemiology and molecular carcinogenesis
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Hepatocellular carcinoma: epidemiology and molecular carcinogenesis
@ast
Hepatocellular carcinoma: epidemiology and molecular carcinogenesis
@en
Hepatocellular carcinoma: epidemiology and molecular carcinogenesis
@nl
type
label
Hepatocellular carcinoma: epidemiology and molecular carcinogenesis
@ast
Hepatocellular carcinoma: epidemiology and molecular carcinogenesis
@en
Hepatocellular carcinoma: epidemiology and molecular carcinogenesis
@nl
prefLabel
Hepatocellular carcinoma: epidemiology and molecular carcinogenesis
@ast
Hepatocellular carcinoma: epidemiology and molecular carcinogenesis
@en
Hepatocellular carcinoma: epidemiology and molecular carcinogenesis
@nl
P3181
P1433
P1476
Hepatocellular carcinoma: epidemiology and molecular carcinogenesis
@en
P2093
Hashem B El-Serag
P304
P3181
P356
10.1053/J.GASTRO.2007.04.061
P407
P577
2007-06-01T00:00:00Z